PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsJuvenile arthritis
MeSH D001171 - juvenile arthritis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D012216:Rheumatic diseases
175 Companies
32 Drugs
$
Success rate
D001168:Arthritis
15 Companies
8 Drugs
$
Success rate
D001327:Autoimmune diseases
1 Company
1 Drug
$
Success rate
D001171: 
Juvenile arthritis
137 Companies
24 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Abbott BiotherapeuticsAdalimumab Trudexa  2003-09-01   
Ibuprofen Ibu  1989-12-18   
Ibuprofen Ibuprofen  1985-06-14   
AbbVieAdalimumab Humira  2002-12-31 $8,993 M Y2024 
Ibuprofen, Hydrocodone Vicoprofen  1997-09-23   
Able LaboratoriesNaproxen Naproxen  2003-08-22   
Accord HealthcareMethotrexate Methotrexate  2007-04-30   
Ajanta PharmaEsomeprazole, Naproxen Naproxen Esomeprazole Magnesium  2022-10-06   
Alembic PharmaceuticalsDiclofenac Diclofenac  2022-07-27   
Methotrexate Methotrexate  2024-06-03   
Alkem LaboratoriesIbuprofen Ibuprofen  2021-09-13   
Famotidine, Ibuprofen Ibuprofen Famotidine  2021-08-03   
Diclofenac Diclofenac Potassium  2022-07-20   
AllerganNaproxen Naproxen  1995-02-10   
Esomeprazole, Naproxen Naproxen Esomeprazole Magnesium  2022-08-24   
Sulfasalazine Sulfasalazine  1982-01-01   
Diclofenac Diclofenac  1996-03-26   
Diclofenac, Misoprostol Diclofenac Misoprostol  2012-07-09   
Ibuprofen, Hydrocodone Hydrocodone Ibuprofen  2003-12-31   
Ibuprofen Ibuprofen  1985-09-06   
Oxycodone, Ibuprofen Oxycodone Ibuprofen  2007-11-26   
Diclofenac Diclofenac Potassium  1998-11-27   
AlraIbuprofen Ibu-tab  1988-08-11   
Altaire PharmaceuticalsDiclofenac Diclofenac  2015-11-16   
1
2
3
4
5
6
...
14
>
Clinical Trials
Historical Success Rate
Phase 1
81%
13/16
Phase 2
55%
6/11
Phase 3
64%
30/47
Approved: 19Overall Success rate: 28%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Abbott Biotherapeutics
Adalimumab,
Ibuprofen,
Ibuprofen lysine,
Lampalizumab
AbbVie
Adalimumab,
Bevifimod,
Polyglycolic acid
Allergan
Diclofenac,
Diclofenac epolamine,
Esomeprazole,
Esomeprazole strontium,
Ibuprofen,
Ibuprofen lysine,
Oxycodone
Amgen
Adalimumab,
Terfenadine,
Dexibuprofen,
Bevifimod,
Nepidermin,
Polyglycolic acid,
Microcrystalline cellulose,
Solumedrol,
Articular,
Antacid
Amneal Pharmaceuticals
Diclofenac,
Diclofenac epolamine,
Methotrexate
1
2
3
4
5
6
...
10
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use